marijuana stocks news

mCig, Inc. (MCIG)

 
Income Statement Get Income Statement for:
View: Annual Data | Quarterly Data All numbers in thousands
Period Ending Jan 31, 2015 Oct 31, 2014 Jul 31, 2014 Apr 30, 2014
Total Revenue 88   160   196   270  
Cost of Revenue 28 69 97 127
Gross Profit 61   91   98   143  
Operating Expenses
Research Development – – – –
Selling General and Administrative 803 868 1,153 238
Non Recurring – – – –
Others 2 2 2 2
Total Operating Expenses – – – –
Operating Income or Loss (744) (779) (1,057) (97)
Income from Continuing Operations
Total Other Income/Expenses Net – – – –
Earnings Before Interest And Taxes (744) (779) (1,057) (97)
Interest Expense – – – –
Income Before Tax (744) (779) (1,057) (97)
Income Tax Expense – – – –
Minority Interest – – – –
Net Income From Continuing Ops (744) (779) (1,057) (97)
Non-recurring Events
Discontinued Operations – – – –
Extraordinary Items – – – –
Effect Of Accounting Changes – – – –
Other Items – – – –
Net Income (744) (779) (1,057) (97)
Preferred Stock And Other Adjustments – – – –
Net Income Applicable To Common Shares (744) (779) (1,057) (97)

MAPH Enterprises, LLC | (305) 414-0128 | 1501 Venera Ave, Coral Gables, FL 33146 | new@marijuanastocks.com
Leave a Reply

Your email address will not be published. Required fields are marked *

You May Also Like

 Aurora Cannabis Inc. (ACBFF) and Alcanna Enter into Exclusive License Agreement

Aurora Cannabis and Alcanna Enter into Exclusive License Agreement for Alcanna Operated,…

Leafbuyer Technologies, Inc. (LBUY) and Flowhub Announce Integration to Offer Instantaneous Dispensary Menu

Leafbuyer Technologies, Inc. and Flowhub Announce Integration to Offer Instantaneous Dispensary Menu…

Innovative Industrial Properties, Inc. (IIPR) Properties Declares First Quarter 2023 Dividends

Innovative Industrial Properties Declares First Quarter 2023 Dividends Innovative Industrial Properties, Inc.…

Tetra Bio-Pharma Inc. (TBPMF) Receives Health Canada Approval for Phase 2 Cannabis Oil Trial

Tetra Bio-Pharma Receives Health Canada Approval for Phase 2 Cannabis Oil Trial…